The National Tuberculosis Treatment Expert Group believes that proper diagnosis and proper end-of-treatment treatment of tuberculosis is needed in all population groups. In this way, the health of an individual patient is protected and the community is protected from the risk of infection. a person live. Continuity in the treatment of tuberculosis must be ensured in all situations, even if the person has not been granted asylum in our country or has no full right to diagnosis and treatment of diseases on the basis of their country of origin. Otherwise, it will promote the spread of resistant tuberculosis. The disease is treatable, it is unethical to be untreated.
It builds on its position on the World Health Organization (WHO) guidelines and pan-European expertise and on the European Center for Disease Prevention and Control (ECDC) (Dara et al. Eur Respir J 2016, ECDC Review of Priorities 2016).
The Tuberculosis Treatment Expert Group provides guidance to physicians treating patients in difficult-to-treat tuberculosis cases nationwide. The group is attended by a specialist in lung diseases and infectious diseases at each university hospital, a pediatric infectious medicine specialist and a representative of the mycobacterial laboratory at the Health and Welfare Institute (THL). Tuula Vasankari, Secretary General of Filha ry, is the head of the group.
For more information, please contact: Tuula Vasankari, Professor, Secretary General Filha ry